Venera Lo Re v. Janssen Pharmaceuticals, Inc. et al
| Venera Lo Re |
| Dr. Richard Patrick Sullivan, MD Sylvia Park, JOHNSON & JOHNSON, Janssen Research & Development LLC, Alexander Medical Group, PC, JANSSEN PHARMACEUTICALS INC and Rochester Regional Health |
| INVOKANA (CANAGLIFLOZIN) PRODUCTS LIABILITY LITIGATION |
| 3:2019cv14108 |
| June 21, 2019 |
| US District Court for the District of New Jersey |
| Lois H Goodman |
| Brian R Martinotti |
| Tort Product Liability |
| 28 U.S.C. § 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 25, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 34 ANSWER to Complaint by JANSSEN PHARMACEUTICALS INC, JOHNSON & JOHNSON, Janssen Research & Development LLC.(ZOGBY, MICHAEL) |
| Filing 33 Clerk's Notice to Counsel. (dm ) |
| Judge Brian R. Martinotti and Magistrate Judge Lois H. Goodman added. (jdb) |
| Filing 32 Certified Copy of Transfer Order and docket received, Case transferred in from District of New York Western; Case Number 6:19-cv-06170. Original file certified copy of transfer order and docket sheet received. |
| Filing 31 MULTIDISTRICT LITIGATION TRANSFER ORDER transferring the action to the District of New Jersey. Signed by Sarah S. Vance, Chair of the Panel on Multidistrict Litigation. (LB) |
| Filing 30 Minute Entry for proceedings held before Hon. Michael A. Telesca: Motion was submitted without roal argument on 5/16/2019 re #20 MOTION to Sever the Claims against Medical Defendants or Drop Medical Defendants Under Federal Rule of Civil Procedure 21 and in Opposition to Plaintiff's Motion to Remand filed by Johnson & Johnson, Janssen Pharmaceuticals, Inc., Janssen Research & Development LLC. (JMC) |
| Filing 29 RESPONSE in Support re #20 MOTION to Sever the Claims against Medical Defendants or Drop Medical Defendants Under Federal Rule of Civil Procedure 21 and in Opposition to Plaintiff's Motion to Remand REPLY MEMORANDUM OF DEFENDANTS JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH & DEVELOPMENT, LLC, AND JOHNSON & JOHNSON IN SUPPORT OF CROSS-MOTION TO DROP THE MEDICAL DEFENDANTS OR SEVER THE CLAIMS AGAINST THEM UNDER FEDERAL RULE OF CIVIL PROCEDURE 21 filed by Janssen Pharmaceuticals, Inc., Janssen Research & Development LLC, Johnson & Johnson. (Attachments: #1 Exhibit Exhibit A)(Murdica, James) |
| Filing 28 Minute Entry for proceedings held before Hon. Michael A. Telesca: Motion was submitted without oral argument on 5/8/2019 re #2 First MOTION to Stay All Proceedings filed by Johnson & Johnson, Janssen Pharmaceuticals, Inc., Janssen Research & Development LLC. (JMC) |
| E-Filing Notification: FYI #26 MEMORANDUM in Support re #20 MOTION to Sever and #27 MEMORANDUM in Support re #20 MOTION to Sever appear to be duplicate filings. (TF) |
| Filing 27 MEMORANDUM in Support re #20 MOTION to Sever the Claims against Medical Defendants or Drop Medical Defendants Under Federal Rule of Civil Procedure 21 and in Opposition to Plaintiff's Motion to Remand filed by Sylvia Park. (Attachments: #1 Certificate of Service Brief in Support of Cross-Motion)(Bernacki, Thomas) |
| Filing 26 MEMORANDUM in Support re #20 MOTION to Sever the Claims against Medical Defendants or Drop Medical Defendants Under Federal Rule of Civil Procedure 21 and in Opposition to Plaintiff's Motion to Remand filed by Alexander Medical Group, PC. (Attachments: #1 Certificate of Service Brief in Support of Cross-Motion)(Bernacki, Thomas) |
| Filing 25 RESPONSE in Opposition re #20 MOTION to Sever the Claims against Medical Defendants or Drop Medical Defendants Under Federal Rule of Civil Procedure 21 and in Opposition to Plaintiff's Motion to Remand filed by Venera Lo Re. (Attachments: #1 Certificate of Service)(Wolford, Kelly) |
| Filing 24 RESPONSE in Opposition re #20 MOTION to Sever the Claims against Medical Defendants or Drop Medical Defendants Under Federal Rule of Civil Procedure 21 and in Opposition to Plaintiff's Motion to Remand filed by Richard Patrick Sullivan. (Attachments: #1 Certificate of Service)(Roach, Michael) |
Filing 23
STIPULATION AND ORDER that Janssen Defendants' time to respond to the Complaint is extended to the later of July 1, 2019 or 30 days after the Judicial Panel on Multidistrict Litigation rules on Plaintiff's pending Motion to Vacate. Signed by Hon. Michael A. Telesca on 4/30/19. (JMC)
|
| Filing 22 STIPULATION and Proposed Order Further Extending Defendants Janssen Pharmaceuticals, Inc., Janssen Research & Development LLC and Johnson & Johnson's Time to Respond to the Complaint by Janssen Pharmaceuticals, Inc., Janssen Research & Development LLC, Johnson & Johnson. (Murdica, James) |
| Filing 21 Minute Entry for proceedings held before Hon. Michael A. Telesca: Motion was submitted without oral argument on 4/29/2019 re #11 First MOTION to Remand to State Court Supreme Court, Monroe County filed by Venera Lo Re. (JMC) |
| E-Filing Notification: #20 CROSS MOTION to Sever. Modified entry to add Cross Motion. (TF) |
| NOTICE: Set/Reset Deadlines as to #20 MOTION to Sever the Claims against Medical Defendants or Drop Medical Defendants Under Federal Rule of Civil Procedure 21 and in Opposition to Plaintiff's Motion to Remand. Responses due by 5/8/2019. Replies due by 5/15/2019. Motion will be submitted without oral argument on 5/16/2019 before Hon. Michael A. Telesca. No court appearances are required. (JMC) |
| Filing 20 CROSS MOTION to Sever the Claims against Medical Defendants or Drop Medical Defendants Under Federal Rule of Civil Procedure 21 and in Opposition to Plaintiff's Motion to Remand by Janssen Pharmaceuticals, Inc., Janssen Research & Development LLC, Johnson & Johnson. (Attachments: #1 Memorandum in Support, #2 Declaration, #3 Exhibit, #4 Exhibit, #5 Exhibit, #6 Exhibit)(Murdica, James) Modified on 4/24/2019 (TF). |
| E-Filing Notification: Incorrect.pdf file attached to entry. Action required: re-file entry with correct attachment and new proof of service #19 Corporate Disclosure Statement by Sylvia Park. (TF) |
| Filing 19 Corporate Disclosure Statement by Sylvia Park. (Attachments: #1 Certificate of Service)(Bernacki, Thomas) |
| Filing 18 Corporate Disclosure Statement by Alexander Medical Group, PC. (Attachments: #1 Certificate of Service)(Bernacki, Thomas) |
| Filing 17 Corporate Disclosure Statement by Rochester Regional Health. (Attachments: #1 Certificate of Service)(Crowley, Emily) |
| ATTENTION CORPORATION PLAINTIFFS/DEFENDANTS: All Corporate Disclosure Statements pursuant to Fed.R.Civ.7.1(b) are to be filed within seven(7) days of this notice. (MD) |
| Filing 16 NOTICE of Appearance by Thomas M. Bernacki on behalf of Sylvia Park (Attachments: #1 Certificate of Service)(Bernacki, Thomas) |
| Filing 15 NOTICE of Appearance by Thomas M. Bernacki on behalf of Alexander Medical Group, PC (Attachments: #1 Certificate of Service)(Bernacki, Thomas) |
| Filing 14 NOTICE of Appearance by Bryan Paul Kroetsch on behalf of Richard Patrick Sullivan (Kroetsch, Bryan) |
| Filing 13 NOTICE of Appearance by Mollie Catherine McGorry on behalf of Richard Patrick Sullivan (McGorry, Mollie) |
| Filing 12 NOTICE of Appearance by Michael J. Roach on behalf of Richard Patrick Sullivan (Roach, Michael) |
| NOTICE: Set/Reset Deadlines as to #2 First MOTION to Stay All Proceedings. Responses due by 4/28/2019. Replies due by 5/6/2019. Motion will be submitted without oral argument on 5/8/2019 before Hon. Michael A. Telesca. No court appearances are required. (JMC) |
| NOTICE: Set/Reset Deadlines as to #11 First MOTION to Remand to State Court Supreme Court, Monroe County. Responses due by 4/23/2019. Motion will be submitted without oral argument on 4/29/2019 before Hon. Michael A. Telesca. No court appearances are required. (JMC) |
| Filing 11 First MOTION to Remand to State Court Supreme Court, Monroe County by Venera Lo Re. (Attachments: #1 Affidavit Attorney Affirmation in Support of Motion, #2 Appendix Attachment 1 (Brief in Support of Vacating CTO), #3 Memorandum in Support, #4 Certificate of Service)(Wolford, Kelly) |
| Filing 10 AMENDED DOCUMENT by Venera Lo Re. Amended Certificate of Service of #9 Affirmation in Response to Motion for Stay. Corrects the document which was electronically served. (Wolford, Kelly) Modified on 4/3/2019 (TF). |
| E-Filing Notification: #10 AMENDED DOCUMENT by Venera Lo Re. Amended Certificate of Service of #9 Affirmation in Response to Motion for Stay. Modified on 4/3/2019 to link document. (TF) |
| Filing 9 AFFIRMATION signed by Kelly C. Wolford filed by Venera Lo Re Affirmation in Response to Motion to Stay Proceedings filed by Venera Lo Re. (Attachments: #1 Certificate of Service)(Wolford, Kelly) |
| Filing 8 NOTICE of Appearance by Kelly Christine Wolford on behalf of Venera Lo Re (Attachments: #1 Certificate of Service)(Wolford, Kelly) |
| Filing 7 CERTIFICATE OF SERVICE by Rochester Regional Health re #6 Affidavit in Support of Motion (Crowley, Emily) |
| Filing 6 AFFIDAVIT in Support re #2 First MOTION to Stay All Proceedings filed by Rochester Regional Health. (Crowley, Emily) |
| Filing 5 NOTICE of Appearance by Emily Durki Crowley on behalf of Rochester Regional Health (Crowley, Emily) |
|
Filing 4
STIPULATION AND ORDER extending time for defendants to respond to complaint until April 28, 2019. Signed by Hon. Michael A. Telesca on 3/25/19. (JMC)
|
| Filing 3 STIPULATION extending time to respond to complaint by Janssen Pharmaceuticals, Inc., Janssen Research & Development LLC, Johnson & Johnson. (Murdica, James) |
| NOTICE: Set/Reset Deadlines as to #2 First MOTION to Stay All Proceedings. Responses due by 4/1/2019. Replies due by 4/8/2019. Motion will be submitted without oral argument on 4/18/2019 before Hon. Michael A. Telesca. No court appearances are required. (JMC) |
| Filing 2 First MOTION to Stay All Proceedings by Janssen Pharmaceuticals, Inc., Janssen Research & Development LLC, Johnson & Johnson. (Attachments: #1 Memorandum in Support, #2 Affidavit)(Murdica, James) |
| Case assigned to Hon. Michael A. Telesca. Notification to Chambers of on-line civil opening. (TF) |
| AUTOMATIC REFERRAL to Mediation The ADR Plan is available for download at http://www.nywd.uscourts.gov/alternative-dispute-resolution(TF) |
| Notice of Potential Tag-Along Action emailed to the MDLl (TF) |
| Notice of Availability of Magistrate Judge: A United States Magistrate of this Court is available to conduct all proceedings in this civil action in accordance with 28 U.S.C. 636c and FRCP 73. The Notice, Consent, and Reference of a Civil Action to a Magistrate Judge form (AO-85) is available for download at http://www.uscourts.gov/services-forms/forms. (TF) |
| Filing 1 NOTICE OF REMOVAL by All Defendants Janssen Pharmaceuticals, Inc., Janssen Research & Development, LLP and Johnson & Johnson from State of New York Supreme Court County of Monroe, case number E2019000845. (Filing fee $ 400 receipt number 0209-3382535), filed by All Defendants. (Attachments: #1 Index Identifying Documents Filed/Served in State Court, #2 Exhibit, #3 Certificate of Service, #4 Corporate Disclosure, #5 Civil Cover Sheet)(Murdica, James) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
